Dr. Lawson most recently served as president and CEO of Humacyte, a regenerative medicine company, according to a March 8 news release from VarmX. He previously served as director of clinical trials for the department of surgery at Duke University Medical Center in Durham, N.C.
Dr. Lawson is succeeding Pieter Reitsma, PhD, founder of VarmX, who will serve as special adviser to the company’s board, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
